Objective: People with migraine present with varying pain extent and an expanded distribution of perceived pain may reflect central sensitization. The relationship between pain extent and clinical features, psychological outcomes, related disability, and pressure pain sensitivity in migraine has been poorly investigated. Our aim was to investigate whether the perceived pain extent, assessed from pain drawings, relates to measures of pressure pain sensitivity, clinical, psychological outcomes, and related disability in women with episodic migraine.
M
igraine is a primary headache disorder with a worldwide prevalence of 5% to 12%. 1 It is well accepted that migraine is associated with a deficient regulation of excitatoryinhibitory balance leading to facilitation of nociceptive gain and sensitization of the trigeminocervical nucleus caudalis and third-order neurons. 2, 3 Several studies have reported that people with migraine may exhibit pressure pain hyperalgesia within the trigeminocervical area as a clinical manifestation of central nervous system hyper-excitability. [4] [5] [6] [7] A recent study has also confirmed the presence of widespread pressure pain hypersensitivity over trigeminal and extratrigeminal areas in individuals with episodic and chronic migraine suggesting that the sensitization process is present from the onset of the condition. 8 Pain drawings are used to obtain a graphic representation of pain location and distribution in individuals with musculoskeletal pain, for example, low back pain. 9 It is accepted that larger pain extent represents a clinical sign of central sensitization 10, 11 and enlarged areas of pain have been associated with more severe pain 12 and greater pressure-pain hypersensitivity 13 in individuals with painful knee osteoarthritis. Similarly, larger pain extent has been associated with higher disability and depression in people with chronic whiplash-associated disorders. 14 These results suggest that the pain drawing, and quantification of pain extent, can assist clinicians to identify individuals with facilitated central nociceptive gain or worse clinical features. Nevertheless, these findings have only been evaluated in people with musculoskeletal pain disorders. [12] [13] [14] As migraine is mainly attributed to a deficient regulation of excitatory-inhibitory balance, the relation between pain extent, central sensitization, and clinical features may be less obvious. Nevertheless, it is relevant to evaluate these associations to better understand the usefulness of the pain drawing for detecting signs of central sensitization in this patient group. Therefore, it would be interesting to determine these potential associations in people with episodic migraine to identify factors for preventing the evolution to the chronic form of the condition. Accordingly, the aims of the current study were to examine: (1) whether pain extent is related to widespread pressure pain sensitivity in women with episodic migraine; and, (2) to investigate associations between pain extent and clinical variables, psychological variables and related disability parameters. We hypothesized that larger pain extent is associated with greater widespread pressure pain sensitivity and worse clinical and psychological features in women with episodic migraine.
METHODS

Participants
Patients with episodic migraine without aura were recruited from a tertiary university-based hospital from March 2015 to March 2016. Migraine was diagnosed according to the International Classification of Headache Disorders criteria, third edition (ICHD3 beta 2013) down to the third-digit level (code 1.1) by a neurologist with expertise in headache. 15 Migraine features including location, onset of migraine (years), frequency (days/month), duration (hours/attack), and intensity of migraine attacks (numerical pain rating scale, 0 to 10), headache-family history and medication intake were recorded. A neuroimaging examination of the head was performed in all patients to exclude other disorders. They were excluded if presented any of the following criteria: (1) other primary or secondary headaches, including medication overuse headache according to the ICHD3 beta 2013 criteria 15 ; (2) history of neck or head trauma; (3) pregnancy; (4) systemic medical disease, for example, rheumatoid arthritis, lupus erythematous; (5) diagnosis of fibromyalgia; or, (6) positive-response to anesthetic blocks in the cervical spine within the past 6 months. All participants signed an informed consent form before their inclusion in the study. The local Ethics Committee of Hospital Rey Juan Carlos (HRJ 07/14) approved the study design and the study was conducted according to the Declaration of Helsinki.
The evaluation was conducted when all patients were headache-free, and when at least 1 week had elapsed as the last migraine attack to avoid migraine-related allodynia. Participants were asked to avoid any analgesic or muscle relaxant 24 hours before the examination. No change was made to their prophylactic treatment.
Pain Drawings
All patients were requested to draw their pain on 4 different paper body charts of the head: ventral view, dorsal view, and 2 representing a lateral view (left and right). All body charts were printed on A4 sheets and patients were asked to shade their pain using a pencil. Standard instructions were provided to ensure that patients reported both the pain extent during their migraine attacks, independently from the type and severity of pain.
All the A4 sheets including the body chart and the pain drawing were digitized using a commercially available scanner. Two trained operators then reproduced the pain drawings on the scanned body charts on a blank digital body chart using an image analysis software (Inkscape version 0.48). The reliability of the described procedure has been previously confirmed. 16, 17 Finally, pain extent was computed using custom made software presented and evaluated in previous work. 17, 18 The software calculates the number of pixels included within each pain drawing. Any shading outside of the body chart borders were not included in the analysis. Pain extent for each patient was reported as the sum of the pixels in the ventral and dorsal views of the head, and expressed as a percentage of total dorsal and ventral body chart area (ie, 507,778 pixels, frontal: 252,617 pixels, dorsal: 255,166 pixels). Pain frequency maps were generated for the 4 different body charts of the head to illustrate where pain was most frequently perceived by the patients. Pain frequency maps were obtained by overlying all of the pain drawings performed on the same body chart. A colour scale was applied to highlight the percentage of patients that reported pain in a specific region.
Pressure Pain Thresholds (PPT)
The PPT, that is, the amount of pressure where a sensation of pressure first changes to pain, was recorded with an electronic algometer (Somedic AB, Farsta, Sweden). Pressure was applied using a 1 cm 2 probe at a rate of approximately 30 kPa/s. Participants were instructed to press the "stop-button" of the algometer as soon as the pressure resulted in the first sensation of pain. They were trained with a first trial over the wrist extensor muscles of their right forearm. PPT was then assessed bilaterally over the temporalis muscle (trigeminal area), C5/C6 zygapophyseal joint (extratrigeminal area) and the tibialis anterior muscle (pain-free distant site). A mean PPT widespread score was obtained from the mean of the 3 body regions. The order of assessment was randomized between participants. A 30 seconds resting period was allowed between each trial (within and between body regions) to prevent over sensitization. 19 The mean of 3 trials on each point was calculated and used for the analysis. As no side-to-side differences in PPTs were found, the mean of both sides on each point was used for the correlation analysis with pain extent. The reliability of algometry following this procedure is high. 20 
Hospital Anxiety and Depression Scale (HADS)
The HADS was used to determine the presence of anxiety and depressive symptoms. This questionnaire consists of 7-items scored on a 4-points scale ranging from 0 to 3 points to assess anxiety (HADS-A) and other 7-items for depressive (HADS-D) symptoms. 21 Each subscale ranges from 0 to 21 points where higher scores represent higher levels of anxiety or depression symptoms. 21 This questionnaire is considered reliable and valid for assessing anxiety (Cronbach α: 0.83) and depression (Cronbach α: 0.82) separately. 22 In headache patients, the HADS has shown good internal consistency. 23 
State-Trait Anxiety Inventory (STAI)
The STAI is a 40-item scale assessing separate dimensions of state anxiety (items l-20, STAI-S) and trait anxiety (items 21-40, STAI-T). 24 The STAI-S assesses relatively symptoms of anxiety. Participants use a 4-point response scale ranging from "not at all" to "very much," to indicate the extent to which they experience each particular emotion. The STAI-T scale measures a stable propensity to experience anxiety, and tendencies of the participant to perceive stressful situations as threatening. It consists of 20 statements requiring individuals to rate how they generally feel on a 4-point scale. In both scales, total score ranges from 0 to 60 points where higher scores indicate greater state or trait anxiety levels. Both subscales have shown high internal consistency and test-retest reliability. 25 
Migraine-related Disability (MIDAS)
The Migraine Disability Assessment Scale (MIDAS) was used to assess the related disability in daily activities (work or school, family, and social) caused by migraine. 26 This questionnaire consists of 5 questions related to days of partial or total loss within the last 3 months with respect to 3 main activities: (1) paid work or school; (2) household chores; (3) family, social, and leisure activities. The questions ask about the number of days of missed activity or days in which productivity was reduced by at least half
Statistical Analysis
The Shapiro-Wilk normality test revealed that the distribution of data for pain extent and 6 of the clinical parameters (years with migraine, migraine intensity, migraine frequency, migraine duration, HADS-A, MIDAS) significantly deviated from normality. Therefore, nonparametric tests were used in the correlational analysis. Spearman ρ rank-order correlation coefficients (r s ) were used to reveal possible associations between pain extent and self-rated outcomes, that is, clinical migraine pain features, anxiety, depression, related disability, and widespread pressure pain sensitivity. Correlations were considered weak when r < 0.3; moderate when 0.3 < r < 0.7, and strong when r > 0.7. 28 A multivariate regression model including those variables significantly associated with pain extent was conducted to assess the variables that contributed significantly to the variance in the dependent variable that is, pain extent. Statistical analysis was performed using R version 3.2.2. Significance was set to α = 0.05 and the Bonferroni correction was applied (α-adjusted = 0.0036) to account for multiple testing. 29 
RESULTS
From 105 eligible patients with migraine who accepted to participate, 33 were excluded for the following reasons: comorbid headache (n = 20); previous head/neck trauma (n = 7); or pregnancy (n = 6). Finally, a total of 72 patients with migraine were included. Table 1 summarizes clinical and PPT data of the entire sample. Pain extent was 13.4 ± 9.4% across the entire group of women with migraine. Pain frequency maps for the entire sample are illustrated in Figure 1 .
The mean time elapsed from the last migraine attack in the current patient sample was 10 days (95% confidence interval, 9.2-10.8). All patients were taking prophylactic medication at intake, that is, amitriptyline, on a regular basis. Correlations between the area of pain, clinical symptoms and related disability are reported in Table 1 . No significant associations were observed between pain extent and clinical features, psychological variables including anxiety (HADS-A) or depressive (HADS-D) symptoms or with anxiety trait (STAI-T) or anxiety state (STAIT-S) levels. Finally, no significant associations were found between pain extent and PPT scores in either trigeminal, extratrigeminal, distant pain-free areas, or mean PPT score (Table 1) .
DISCUSSION
The degree of pain extent was not associated with clinical, psychological, or disability variables nor with widespread pressure pain sensitivity in women with episodic migraine rejecting the initial hypothesis of the study.
Although it is accepted that people with migraine exhibit pain in the trigeminal area, mostly concentrated on the orbicular and temporalis areas, the evaluation of pain drawings in people with migraine is scarce. In fact, only 2 studies have evaluated the location of pain during migraine attacks in adults 30 and children 31 with migraine. The first showed that, from a total sample of 1283 patients with migraine, around 60% to 65% reported pain in the frontoorbital and temporal areas, whereas occipital and neck pain were present in almost 40% of the sample. 30 The second study observed that 66% of 200 children with migraine reported frontal pain, but the presence of occipital pain was only 12%. 31 However, neither study included an actual evaluation of pain drawings but rather documented pain location based on questions asked to the patients. 30, 31 The pain frequency maps generated from the current study, further supports the observations above as 60% of the patients exhibited pain in the fronto-orbital and/or temporalis areas during their migraine pain attacks. Further, the pain frequency maps also revealed that around 30% of the patient's exhibit pain in the occipital and neck area. Thus, both the current and previous findings confirm the high prevalence of concomitant neck pain in individuals with migraine. 32 Larger pain extent and widespread pressure hypersensitivity have been associated with stronger sensitization 8, 10, 11 ; however, in the current study we did not observe any association between pain extent in the trigeminocervical area and widespread pressure sensitivity. This is in contrast with the results observed in other painful conditions such as knee osteoarthritis where larger pain extent was associated with higher pressure hypersensitivity. 13 Similarly, the present study did not find associations between pain extent and clinical, psychological and related disability outcomes in our sample of women with episodic migraine that is in disagreement with previous findings reported for other pain conditions, for example, knee osteoarthritis 12 or chronic whiplash-associated disorders. 14 Our results support the findings of Kelman, 30 which showed that headache location was not correlated with lifetime duration of migraine, intensity, time to peak of headache, recurrence frequency, and time to recurrence. One possible explanation for the discrepancy between the current results and those observed in people with whiplash-associated disorders or osteoarthritis, could be related to the fact that both osteoarthritis and whiplash are musculoskeletal disorders whereas migraine is attributed to deficient regulation of excitatory-inhibitory balance. Therefore, the potential relationship between pain extent, clinical, psychological, and sensitization outcomes may be less clear. It is also possible that the presence of more widespread symptoms extending beyond the head and neck area 33 is more related to sensitization outcomes. Finally, it is also plausible that the inclusion of episodic, not chronic, migraine explains the lack of associations. In fact, all patients in our sample were taking prophylactic treatment on a regular basis, which could have influenced the results. Nevertheless, the lack of association between pain extent and psychological outcomes, including anxiety and depression, confirms that expanded pain drawings are not always associated with psychological state. 34 This is the first study utilizing a novel software for extracting pain extent from pain drawings in a sample of women with migraine. This is a strength of the study as pain extent could be analyzed without any subjective influence from an operator and thus the software used to estimate pain extent eliminates estimation errors. However, we should recognize that the pain drawings were first drawn on paper body charts, and later scanned. It would be relevant to determine if pain drawings using electronics devices, for example, on a tablet, instead of paper body charts would lead similar results. In addition, some potential methodological considerations should be mentioned. First, we collected data from a sample of women with episodic migraine; therefore, current results should not be extrapolated to chronic migraine or to men. It would be interesting to determine if any association is observed in people with chronic migraine and this should be explored in future studies. Second, although the reliability of the assessment method has been shown to be high in people with musculoskeletal pain, 18 we did not evaluate the reliability of pain location over time in our sample of patients with migraine. This might be relevant in individuals with migraine as pain drawings were obtained when patients were headache-free and when at least 1 week had elapsed as the last migraine attack and, therefore, a potential recall of bias can be present. Nevertheless, as patients in our sample suffered from migraine for more than 15 years, this seems unlikely. It would be relevant to determine longitudinal changes in pain extent in people with migraine and to see if differences are observed between the episodic and chronic forms of the condition. Third, we collected static outcomes of sensitization and only from 1 stimuli, pressure thresholds. We do not know if pain extent is associated with other manifestations of sensitization such as wind-up, spatial or temporal summation, or conditioned pain modulation. Finally, we did not ask the participants to report pain in other locations of their body and perhaps widespread pain across the entire body is associated with psychological factors or sensitization in individuals with migraine.
CONCLUSIONS
This study utilised a reliable procedure to quantify pain extent in women with migraine. Pain extent within the trigeminocervical area did not correlate with the degree of sensitization or any other clinical features in women with episodic migraine. Further research is needed to determine if the presence of expanded pain areas outside of the trigeminal-cervical area can play a relevant role in the sensitization processes in migraine.
